Protalix BioTherapeutics Letter to Stockholders
CARMIEL, Israel , Jan. 5, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization...
Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
Company to host conference call and webcast today at 8:00 a.m. EST
Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results
Company to host conference call and webcast today at 8:30 a.m. EDT
Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025
Company to host conference call and webcast at 8:30 a.m. EDT